Association of ANRIL (rs1333045) Gene Polymorphism with the Risk of Acute Myeloid Leukemia

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 364

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

NSCMRMED03_210

تاریخ نمایه سازی: 30 دی 1397

چکیده مقاله:

Background and Aim: Dysregulation of cell cycle genes can lead todifferent kind of cancers. It has become apparent that lncRNAs are animportant regulator of the gene expression. Promotor polymorphisms are one of the main reasons for gene expression dysregulation. ANRILwhich also known as CDKN2B-AS is a lncRNA that located within thep15/CDKN2B-P16/CDKN2A-p14/ARF gene cluster. Single nucleotidepolymorphisms of this gene are associated with many diseases,particularly cancers. The aim of this study was to evaluate the associationof ANRIL polymorphism with acute myeloid leukemia in Iranian patientsMethods: In the present study, AML patient and age- and sex-matchedcontrol were included.Results: The results showed no significant association of alleles andgenotype frequency of ANRIL (rs1333045) polymorphism between AMLpatients and control subjects.Conclusion: We didn’t find a significant association between ANRIL(rs1333045) polymorphism and the risk of acute myeloid leukemia.

نویسندگان

Hamid Fallah

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Taheri

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Iman Azari

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Arezoo Sayad

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran